Literature DB >> 25559264

Aortic stenosis is largely a boney affair.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559264     DOI： 10.1007/s00109-014-1245-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  11 in total

Review 1.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 2.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

Review 3.  Leucine-rich repeat glycoproteins of the extracellular matrix.

Authors:  A M Hocking; T Shinomura; D J McQuillan
Journal:  Matrix Biol       Date:  1998-04       Impact factor: 11.583

Review 4.  Aortic-valve stenosis--from patients at risk to severe valve obstruction.

Authors:  Catherine M Otto; Bernard Prendergast
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

Review 5.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

6.  Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2.

Authors:  Habib Derbali; Yohan Bossé; Nancy Côté; Philippe Pibarot; Audrey Audet; Andree Pépin; Benoit Arsenault; Christian Couture; Jean-Pierre Després; Patrick Mathieu
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

Review 7.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

8.  BMP-2 and TGF-β1 mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells.

Authors:  Rui Song; David A Fullerton; Lihua Ao; Daniel Zheng; Ke-seng Zhao; Xianzhong Meng
Journal:  J Mol Med (Berl)       Date:  2014-11-22       Impact factor: 4.599

9.  The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.

Authors:  Xiao-Dong Chen; Larry W Fisher; Pamela Gehron Robey; Marian F Young
Journal:  FASEB J       Date:  2004-06       Impact factor: 5.191

10.  Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2.

Authors:  Rui Song; Qingchun Zeng; Lihua Ao; Jessica A Yu; Joseph C Cleveland; Ke-Seng Zhao; David A Fullerton; Xianzhong Meng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.